RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons and is itself regulated by lysine mono-methylation. [electronic resource]

By:

Carlson, Scott M

Contributor(s):

Soulette, Cameron M
Yang, Ze
Elias, Joshua E
Brooks, Angela N
Gozani, Or

Producer: 20170825Description: 13381-13390 p. digitalISSN:

1083-351X

Subject(s):

Alternative Splicing
Cell Line
Cell Proliferation
Cell Survival
Exons
Gene Expression Profiling
Gene Expression Regulation
High-Throughput Nucleotide Sequencing
Humans
Immobilized Proteins -- chemistry
Immunoprecipitation
Lysine -- metabolism
Methylation
Nuclear Proteins
Protein Interaction Domains and Motifs
Protein Processing, Post-Translational
Proteomics -- methods
RNA Precursors -- chemistry
RNA, Messenger -- chemistry
RNA-Binding Proteins -- chemistry
Recombinant Fusion Proteins -- chemistry
Serine-Arginine Splicing Factors -- chemistry
Spliceosomes -- metabolism

Online resources:

Available from publisher's website

In: The Journal of biological chemistry vol. 292

Tags from this library: No tags from this library for this title. Log in to add tags.

Star ratings

Cancel rating. Average rating: 0.0 (0 votes)

Holdings ( 0 )
Title notes ( 1 )
Comments ( 0 )

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

Browse results Close

Back to results

1 Sex difference in immune response to vaccination: A participant-level meta-analysis of randomized trials of IMVAMUNE smallpox vaccine.
by Troy, Jesse D
2 Use of biological assignment in hematopoietic stem cell transplantation clinical trials.
by Logan, Brent
3 Phase II randomized trial of cisplatin and WR-2721 versus cisplatin alone for metastatic melanoma: an Eastern Cooperative Oncology Group Study (E1686).
by Glover, Donna
4 Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults.
by Belshe, Robert B
5 Twenty-four-hour urine insulin as a measure of hyperinsulinaemia/insulin resistance before onset of pre-eclampsia and gestational hypertension.
by Emery, Stephen P
6 Abortion, changed paternity, and risk of preeclampsia in nulliparous women.
by Saftlas, Audrey F
7 Correlate of immune protection against HSV-1 genital disease in vaccinated women.
by Belshe, Robert B
8 The effect of unrelated donor marrow transplantation on health-related quality of life: a report of the unrelated donor marrow transplantation trial (T-cell depletion trial).
by Altmaier, Elizabeth M
9 Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response.
by Tomblyn, Marcie R
10 Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women.
by Bernstein, David I
11 A Phase 2, Randomized, Control Trial of Group B Streptococcus (GBS) Type III Capsular Polysaccharide-tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Colonization With GBS III.
by Hillier, Sharon L
12 HSV-1 and HSV-2 seroprevalence in the united states among asymptomatic women unaware of any herpes simplex virus infection (Herpevac Trial for Women).
by Schulte, Joann M
13 Efficacy results of a trial of a herpes simplex vaccine.
by Belshe, Robert B
14 Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels.
by Tolar, Jakub
15 Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation study.
by Anderlini, Paolo
16 Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial.
by Krishnan, Amrita

RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons and is itself regulated by lysine mono-methylation.

APA

Carlson S. M., Soulette C. M., Yang Z., Elias J. E., Brooks A. N. & Gozani O. (20170825). RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons and is itself regulated by lysine mono-methylation. : The Journal of biological chemistry.

Chicago

Carlson Scott M, Soulette Cameron M, Yang Ze, Elias Joshua E, Brooks Angela N and Gozani Or. 20170825. RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons and is itself regulated by lysine mono-methylation. : The Journal of biological chemistry.

Harvard

Carlson S. M., Soulette C. M., Yang Z., Elias J. E., Brooks A. N. and Gozani O. (20170825). RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons and is itself regulated by lysine mono-methylation. : The Journal of biological chemistry.

MLA

Carlson Scott M, Soulette Cameron M, Yang Ze, Elias Joshua E, Brooks Angela N and Gozani Or. RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons and is itself regulated by lysine mono-methylation. : The Journal of biological chemistry. 20170825.

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Simple DC-RDF

OAI-DC

SRW-DC